SLC2A1 and cancer: Elevated expression of several key glycolytic enzymes, including SLC2A1/GLUT1, HK2, ENO1, PGK1, PDK1, PDK4, and PFKFB3, was found to correlate with resistance in some cancer cell lines and clinical tissue samples [69] (see also Supplementary Table S1).